Biologic anti-IL17 drugs in erythrodermic psoriasisCapsule Summary

• Asıl Yazarlar: Alessandro Falco, MD (Yazar), Cristina Mugheddu, MD (Yazar), Jasmine Anedda, MD (Yazar), Laura Pizzatti, MD (Yazar), Alice Tatti, MD (Yazar), Brunella Conti, MD (Yazar), Laura Atzori, MD (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Erythrodermic psoriasis (EP) is a potentially life-threatening disease, and there is currently no consensus regarding its optimal treatment. Biological drugs approved for Psoriasis Vulgaris treatment have been used as alternatives to traditional medications. Objective: To evaluate the cl...